Monitoring HPV type-specific prevalence over time through clinic-based surveillance: A perspective on vaccine effectiveness

被引：6

作者：

Gaffga, N. H. ^{[1
]}

Flagg, E. W. ^{[1
]}

Weinstock, H. S. ^{[1
]}

Shlay, J. C. ^{[2
]}

Ghanem, K. G. ^{[3
]}

Koutsky, L. A. ^{[4
]}

Kerndt, P. R. ^{[5
]}

Hsu, K. K. ^{[6
]}

Unger, E. R. ^{[7
]}

Datta, S. D. ^{[1
]}

机构：

[1] Ctr Dis Control & Prevent, Epidemiol & Surveillance Branch, Div STD Prevent, Natl Ctr HIV Viral Hepatitis STD & TB Prevent, Atlanta, GA 30333 USA

[2] Denver Publ Hlth, Denver, CO USA

[3] Johns Hopkins Univ, Sch Med, Baltimore, MD USA

[4] Univ Washington, Seattle, WA 98195 USA

[5] Cty Los Angeles Dept Hlth Serv, STD Program, Los Angeles, CA USA

[6] Massachusetts Dept Publ Hlth, Div STD Prevent, Boston, MA USA

[7] Ctr Dis Control & Prevent, Natl Ctr Zoonot Vectorborne & Enter Infect Dis, Div Viral Resp Dis, Chron Viral Dis Branch, Atlanta, GA 30333 USA

来源：

VACCINE | 2012年 / 30卷 / 11期

关键词：

HPV; HPV vaccine; Clinic-based surveillance; HUMAN-PAPILLOMAVIRUS INFECTION; GENITAL WARTS; NATURAL-HISTORY; CERVICAL-CANCER; UNITED-STATES; LESIONS; IMPACT; WOMEN;

D O I：

10.1016/j.vaccine.2012.01.021

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

We investigated the feasibility of monitoring trends in prevalence of vaccine-preventable human papillomavirus (HPV) types in different clinic populations. We collected cervical specimens from women presenting to family planning, primary care, and sexually transmitted disease (STD) clinics for routine pap smears in five US cities during 2003-2005. We performed HPV genotyping and calculated annual type-specific prevalences; pre-vaccine era prevalence was highest for HPV 16(6.0; 95% confidence interval [CI] 5.5-6.6%) and annual prevalences for vaccine-preventable types were stable, with few exceptions, after controlling for clinic type, age group, and city. With sufficient sample size and stable population characteristics, clinic-based surveillance systems can contribute to monitoring HPV vaccine impact in the cervical screening population. Published by Elsevier Ltd.

引用

页码：1959 / 1964

页数：6

共 22 条

[1] Declining prevalence of cervicovaginal human papillomavirus infection with age is independent of other risk factors [J].

Burk, RD ;

Kelly, P ;

Feldman, J ;

Bromberg, J ;

Vermund, SH ;

Dehovitz, JA ;

Landesman, SH .

SEXUALLY TRANSMITTED DISEASES, 1996, 23 (04) :333-341

[2] Human papillomavirus types in invasive cervical cancer worldwide:: a meta-analysis [J].

Clifford, GM ;

Smith, JS ;

Plummer, M ;

Muñoz, N ;

Franceschi, S .

BRITISH JOURNAL OF CANCER, 2003, 88 (01) :63-73

[3] The use of confidence or fiducial limits illustrated in the case of the binomial. [J].

Clopper, CJ ;

Pearson, ES .

BIOMETRIKA, 1934, 26 :404-413

[4] Human papillomavirus infection and cervical cytology in women screened for cervical cancer in the United States, 2003-2005 [J].

Datta, S. Deblina ;

Koutsky, Laura A. ;

Ratelle, Sylvie ;

Unger, Elizabeth R. ;

Shlay, Judith ;

McClain, Tracie ;

Weaver, Beth ;

Kerndt, Peter ;

Zenilman, Jonathan ;

Hagensee, Michael ;

Suhr, Cristen J. ;

Weinstock, Hillard .

ANNALS OF INTERNAL MEDICINE, 2008, 148 (07) :493-500

[5]

Dixon WJ, 1983, INTRO STAT ANAL, P281

[6] Rapid decline in presentations of genital warts after the implementation of a national quadrivalent human papillomavirus vaccination programme for young women [J].

Fairley, C. K. ;

Hocking, J. S. ;

Gurrin, L. C. ;

Chen, M. Y. ;

Donovan, B. ;

Bradshaw, C. S. .

SEXUALLY TRANSMITTED INFECTIONS, 2009, 85 (07) :499-502

[7] Natural History of Genital Warts: Analysis of the Placebo Arm of 2 Randomized Phase III Trials of a Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Vaccine [J].

Garland, Suzanne M. ;

Steben, Marc ;

Sings, Heather L. ;

James, Margaret ;

Lu, Shuang ;

Railkar, Radha ;

Barr, Eliav ;

Haupt, Richard M. ;

Joura, Elmar A. .

JOURNAL OF INFECTIOUS DISEASES, 2009, 199 (06) :805-814

[8] HUMAN PAPILLOMAVIRUS TYPE-6 AND TYPE-11 DNA-SEQUENCES IN GENITAL AND LARYNGEAL PAPILLOMAS AND IN SOME CERVICAL CANCERS [J].

GISSMANN, L ;

WOLNIK, L ;

IKENBERG, H ;

KOLDOVSKY, U ;

SCHNURCH, HG ;

ZURHAUSEN, H .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (02) :560-563

[9] Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method [J].

Gravitt, PE ;

Peyton, CL ;

Apple, RJ ;

Wheeler, CM .

JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (10) :3020-3027

[10]

Gravitt PE, 2000, J CLIN MICROBIOL, V38, P357

← 1 2 3 →